Turbo tsh 1
Home Up Calcitonin IRMA test Anti-hTG (human thyroglobulin) RIA test TG (thyroglobulin) IRMA test Anti-TPO (thyroid peroxidase) RIA test Turbo tsh 1 Turbo tsh 2 Turbo tsh3 Turbo tsh4 Turbo tsh5 TSH ELISA test Free T4 (thyroxine) RIA test Free T4 Blue T4 (thyroxine) RIA test T4 (thyroxine) RIA test 1 T4 (thyroxine) RIA test 2 T4 (thyroxine) RIA test 3 Free T3 (triiodothyronine) RIA test T3 (triiodothyronine) RIA test T3 (triiodothyronine) RIA test 1 T3 (triiodothyronine) RIA test 2 T3 (triiodothyronine) RIA test 3 Progesterone RIA test Testosterone RIA test Cortisol RIA test DHEA-SO4 (dehydroepiandrosterone sulphate) RIA test hGH (human growth hormone) IRMA test   a hGH (human growth hormone) IRMA test 1  b hLH (luteinizing hormone) IRMA test hLH (luteinizing hormone) IRMA test 1 h FSH (follicle stimulating hormone) IRMA test h FSH (follicle stimulating hormone) IRMA test 1 h Prolactin IRMA test h Prolactin IRMA test 1 Insulin RIA test C-peptide IRMA test SHBG (sex hormone binding globulin) IRMA test AFP (alpha fetoprotein) IRMA test AFP (alpha fetoprotein) IRMA test 1 AFP (alpha fetoprotein) ELISA test 2 ß hCG (beta human chorionic gonadotropin) IRMA test ß hCG (beta human chorionic gonadotropin) IRMA test 1 ß hCG (beta human chorionic gonadotropin) ELISA test 2 hCG (human chorionic gonadotropin) free ß-subunit test 3 h CEA (carcinoembryonic antigen) IRMA test PSA (prostate specific antigen) IRMA test PSA (prostate specific antigen) IRMA test 1 Free PSA (prostate specific antigen) IRMA test PSA (prostate specific antigen) ELISA test Prostaglandin D2 RIA test 8-iso-Prostaglandin F2a RIA test Bicyclo Prostaglandin E2 RIA test 11-Dehydrothromboxane B2 RIA test* 13,14-Dihydro-15-keto-PGF2a RIA test* 6-keto-PGF1a /2,3-dinor-6-keto-PGF1a RIA test Prostaglandin E2 RIA test Prostaglandin F2a RIA test* Thromboxane B2/2,3-dinor-TxB2 RIA test

 

Description - 100 test kit

The hTSH [125I] IRMA system provides a direct quantitative in vitro determination of human thyroid stimulating hormone (hTSH) in human serum. hTSH can be assayed in the range 0-100 µIU/ml using 100 or 200 µl serum sample. Each kit contains materials sufficient for 100 assay tubes permitting the construction of one standard curve and the assay of 40 unknowns in duplicate.

Introduction

The thyroid stimulating hormone (thyrotropin or TSH) is a glycoprotein with a molecular weight of 28000, secreted by the adenohypophysis. Like other glycoprotein hormones (FSH, LH and HCG), TSH contains two different subunits, an alpha- and a ß-chain, linked by noncovalent bounds. The primary structure of alpha subunits of TSH and of the gonadotropins is the same, whilst their ß subunits are different. The ß subunits are responsible for the immunological and biological specificity of these hormones.

The synthesis and the release of TSH are controlled by the circulatory level of thyroid hormones; triiodothyronine (T3) and thyroxine (T4) and by the hypothalamic thyrotropin releasing hormone (TRH). Thyroid hormones regulate the secretion of TSH by a negative feedback mechanism. An elevation of T3 or T4 will suppress, and their fall will, in turn, increase the level of thyroid stimulating hormone in serum. The increased concentration of TSH in the serum is the earliest and best indicator of primary hypothyroidism.

The determination of TSH by immunoassay methods plays a crucial role in the diagnosis of thyroid disorders and in the evaluation of the functional integrity of the hypothalamic-pituitary axis.

The outstanding sensitivity of the present hTSH IRMA system makes it particularly suitable for the measurement of subnormal thyroid stimulating hormone levels, a key to both the diagnosis and treatment follow up of hyperthyroid patients.

Principle of method

The technology uses two high affinity monoclonal antibodies in an immunoradiometric assay (IRMA) system. It offers an increased level of sensitivity and specificity compared with conventional RIA methods.

The 125I labelled signal-antibody binds to an epitope of the hTSH molecule which is different from that recognised by the unlabelled capture-antibody. The two antibodies react simultaneously with the antigen present in standards or samples, which leads to the formation of a capture antibody - antigen - signal antibody complex, also referred to as a “sandwich”.

Standards and samples are incubated with a mixture of the antibodies at room temperature. At the end of a 45 minutes incubation period (no need for a shaker), magnetic immunosorbent (MIS) is added in excess. MIS particles selectively bind the hTSH – signal antibody – capture antibody complex and settle out in a magnetic field. A wash step is critical to reducing non-specific binding to a minimum for increased low-end precision.

The concentration of antigen is directly proportional to the radioactivity measured in test tubes. By constructing a calibration curve plotting binding values against a series of calibrators containing known amount of thyroid stimulating hormone, the unknown concentration of hTSH in patient samples can determined.

Contents of the kit

1 bottle TRACER, ready to use
21 ml, containing < 900 kBq 125I-signal and capture antibody in buffer with red dye and 0.1% NaN3.
8 vials STANDARD, ready to use
1.5 ml per vial, containing 0 (S0), 0.06 (S0.06), 0.15 (S0.15), 0.6 (S0.6), 2.5 (S2.5), 15 (S15), 50 (S50) and 100 (S100) µIU/ml hTSH (WHO 2nd IRP 80/558) in serum with 0.1% NaN3
2 vials CONTROL SERUM low (CI) and high (CII)
1.5 ml, containing 0.1% NaN3

The concentration of the control serum is specified in the quality certificate enclosed.
1 bottle MAGNETIC IMMUNOSORBENT (MIS), ready to use. DO NOT FREEZE!
55 ml, containing paramagnetic particles in buffer with 0.1% NaN3.
1 bottle WASH BUFFER CONCENTRATE.
20 ml, containing 0.1% NaN3. See Preparation of reagents
1 pc Quality certificate
1 pc Pack leaflet

Materials, tools and equipment required

Distilled water
Round bottom polystyrene or polypropylene test tubes, about 12 x 75 mm.
Precision pipettes (100, 200, 500 and 1000 µl)
Vortex mixer
Rack and magnetic separator
Gamma counter
Absorbent tissue

Recommended tools and equipment

Repeating pipettes (e.g. Eppendorf)
Dispenser with 1-L reservoir (instead of the 1 ml pipette)

Specimen collection and storage

Serum samples can be prepared according to common procedures used routinely in clinical laboratory practice. Samples can be stored at 2-8 °C if the assay is carried out within 24 hours, otherwise aliquots should be prepared and stored deep frozen (-20 °C). Frozen samples should be thawed and thoroughly mixed before assaying. Repeated freezing and thawing should be avoided. Do not use lipemic, hemolyzed or turbid specimens.

Preparation of reagents, storage

Add the wash buffer concentrate (20 ml) to 200ml distilled water to obtain 220 ml wash solution. Upon dilution store at 2-8 °C until expiration.

Store the rest of reagents between 2-8 °C after opening. At this temperature each reagent is stable until expiry date. The actual expiry date is given on the package label and in the quality certificate.

CAUTION! Equilibrate all reagents and serum samples to room temperature. Mix all reagents and samples thoroughly before use. Avoid excessive foaming.

The Way of Use

The assay can be used in different procedures. There are two options for running the assay. The procedures are labelled as “A” & “B”. Patient sample values and expected values are the same for both procedures.

OPTION “A”: The Basic Procedure

It is very economical on sample consumption. Only 100 µl sample volume is needed. The sensitivity attainable is 0.015 µIU/ml. At the expiry date of the kit the analytical sensitivity is 0.04 µIU/ml. When the kit has less then 3 weeks to its expiration standard 0.06 µIU/ml can be omitted. However if sample consumption is not critical we recommend you OPTION B.

Standard solution 50 µIU/ml can also be omitted if the curve-fitting algorithm of the gamma counter gives similar results with or without this point.

OPTION “B”: The Hyper Sensitive Method

It works in the same way as OPTION A except the sample volume, which is 200 µl. The sensitivity attainable is 0.008 µIU/ml. At the expiry date of the kit the analytical sensitivity is 0.03 µIU/ml.

OPTION A - The Basic Procedure

(For a quick guide, refer to Table 1.)

1 Dilute the wash buffer concentrate appropriately.
2 Equilibrate reagents and samples to room temperature before use. (Cold reagents will slow down the reaction and warming up rate will be different from tube to tube.)
3 Label test tubes in duplicate for each standard (0 -100 µIU/ml), control serum and patient samples.
4 Homogenize all reagents and patient samples by gentle mixing. Avoid foaming.
5 Pipette 100 µl of standards, control and patient samples into the bottom of labelled tubes.
6 Pipette 200 µl of tracer into each tube. Total count tubes should be set aside for counting.
7 Incubate tubes for 45 minutes at room temperature (20–28 °C).
8 Vigorously shake and swirl the bottle containing magnetic immunosorbent until homogeneity is achieved. Add 500 µl MIS to each tube. Swirl the bottle of MIS after every 15-20 tubes.
9 Thoroughly vortex mix all tubes, and incubate them for 15 minutes at room temperature.
10 Attach the rack on to the magnetic separator base and ensure that every tube is in contact with the base plate. Let the MIS particles settle for 5 minutes. Do not remove the rack from the separator base after the separation of the solid and liquid phases. Pour off and discard the supernatant. Keeping the separator inverted, place the tubes on a pad of absorbent tissue and allow to drain for 2 minutes.
11 Return the separator to an upright position and add 1.0 ml of washing solution to each tube. For more comfort and precision, it is recommended to use either a repeating pipette (e.g. Eppendorf-pipette) or a dispenser with bottle for the addition of washing solution.
12 Vortex mix each tube thoroughly and repeat Step 10. Intense vortexing is required.
13 Count each tube for at least 60 seconds in a gamma counter.
14 Calculate the TSH concentrations of the samples as described in Calculation of results or use special software.

Table 1. Assay Protocol, Pipetting Guide - for OPTION A
All volumes are in microliters (µl).

Tube

Total

Standard

Sample

Control

Standard

 

100

   

Sample

   

100

 

Control

     

100

Tracer

(200)

200

200

200

Vortex mix
Incubate for 45 minutes at room temperature

Magnetic immunosorbent

 

500

500

500

Vortex mix
Incubate for 15 minutes at room temperature

Place the tubes on the magnetic separator for 5 minutes.

Decant the fluid and blot on filter paper

Wash Buffer

 

1000

1000

1000

Vortex mix

Place the tubes on the magnetic separator for 5 minutes.

Decant the fluid and blot on filter paper

Count radioactivity (60 sec/tube)

Calculate the results

Characterization of the assay for OPTION A

Typical standard curve for the Turbo TSH I-125 IRMA kit (Option A)
Figure 1.
OPTION A Typical standard curve corresponding to Table 2.
(Do not use to calculate sample values!)

Table 2. Typical assay data for OPTION A

 

CPM
1

CPM
2

CPM
mean

B/T %

Total

411 237

402 625

406 931

-

S0 (NSB)

117

97

107

0.026

S0.06

297

241

269

0.066

S0.15

518

572

545

0.134

S0.6

1 850

1 924

1 887

0.464

S2.5

7 602

7 736

7 669

1.88

S15

45 678

44 718

45 198

11.11

S50

132 951

131 243

132 097

32.46

S100 (Bmax)

227 699

229 841

228 770

56.22

CI

1 158

1 046

1 102

0.31

CII

59 101

57 811

58 456

19.4

Sensitivity

The analytical sensitivity or minimum detectable limit is calculated by the interpolation of the mean counts of zero standard plus 2 standard deviation from the standard curve. Determination was carried out using 20 replicates of zero standard response.

The value of analytical sensitivity is 0.015 µIU/ml measured using fresh tracer.

The functional sensitivity is a measure of the hTSH concentration that is significantly different from zero as determined by the inter-assay precision profile (22% CV).

The value of functional sensitivity is: 0.09 µIU/ml.

Hook effect

There is no high dose hook effect up to an hTSH concentration 500 µIU/ml.

Precision

The within-assay precision was determined with 15 replicates within a single run, the between-assay precision was estimated in 15 independent runs carried out in duplicates. CV values are summarized below:

Table 3/1.

 

intra-assay

No.

mean (µIU/ml)

CV %

1

0.207

5.8

2

0.737

2.8

3

1.01

3.4

4

1.19

2.6

5

1.89

2.9

6

3.31

1.6

7

6.77

1.2

The between-assay (inter-assay) precision was determined using pooled human serum samples in independent assay runs. The number of measurements on a sample was a function of sample volume available. Three different operators took part in the investigation process and four different tracer batches were used at different ages of the reagents. Four different lots of MIS were used to determine the inter-assay precision profile. Results are presented below.

Table 3/2.

   

inter-assay

sample No.

number of assay runs

mean (µIU/ml)

CV %

1

18

0.049

33.8

2

18

0.079

25.4

3

19

0.090

15.1

4

11

0.095

17.1

5

20

0.124

14.1

6

19

0.143

13.1

7

19

0.196

8.3

Linearity – dilution test

Individual human serum samples were diluted with the zero standard of the kit. The diluted samples were measured according to kit protocol.

Table 4.

sample
No.

dilution factor

expected µIU/ml

observed µIU/ml

recovery
%

1

1

 

18.02

 

1

2.03

8.89

8.62

97.0

1

4.10

4.39

4.38

99.7

1

8.32

2.17

2.14

98.9

2

1

 

33.51

 

2

2.00

16.78

16.06

95.7

2

3.98

8.42

7.96

94.5

2

7.97

4.21

3.93

93.5

3

1

 

34.83

 

3

2.00

17.43

16.81

96.4

3

3.99

8.74

8.91

102.0

3

7.95

4.38

4.15

94.9

4

1

 

28.74

 

4

1.99

14.46

14.31

98.9

4

3.97

7.25

7.53

103.9

4

7.90

3.64

3.85

105.8

5

1

 

27.02

 

5

2.00

13.49

12.47

92.5

5

4.03

6.70

6.36

94.9

5

8.05

3.36

3.32

98.8

6

1

 

44,68

 

6

2.00

22.37

21.10

94.3

6

3.99

11.21

10.40

92.8

6

7,99

5.59

5.19

92.8

7

1

 

25.17

 

7

2.01

12.49

12.10

96.8

7

4.06

6.20

5.96

96.2

7

7.65

3.29

2.90

88.1

8

1

 

7.61

 

8

2.00

3.80

3.70

97.1

8

4.03

1.89

1.78

94.2

8

8.11

0.939

0.869

92.6

9

1

 

109.36

 

9

2.00

54.6

51.94

95.1

9

4.03

27.12

25.22

93.0

9

8.12

13.47

12.51

92.9

10

1

 

42.41

 

10

1.99

21.28

20.63

97.0

10

3.98

10.65

10.25

96.2

10

8.02

5.29

5.25

99.2

Recovery – addition test

Individual human serum samples were spiked with known amount of an elevated stock sample. Recovery % is to be interpreted as = (observed-base)/added*100. The results are summarised below.

Table 5.

sample

base µIU/ml

added µIU/ml

expected µIU/ml

observed µIU/ml

recovery
%

1

8.33

17.27

25.61

25.48

99.3

2

7.36

18.72

26.07

25.39

96.3

3

8.34

18.57

26.90

26.66

98.7

4

8.98

16.39

25.37

25.00

97.7

5

5.18

18.01

23.19

20.84

86.9

6

5.38

15.83

21.20

20.54

95.8

7

10.22

15.79

26.02

26.22

101.3

8

14.44

13.42

27.86

27.46

97.0

9

10.02

13.57

23.59

22.82

94.3

10

0.750

14.35

15.10

14.61

96.6

11

1.46

14.71

16.17

15.90

98.2

12

0.921

14.39

15.31

14.44

94.0

13

0.011

2.66

2.67

2.80

104.9

14

0.013

2.70

2.72

2.95

108.7

15

0.029

2.73

2.76

3.03

109.9

16

0.058

2.65

2.71

3.20

118.5

17

0.102

3.62

3.72

4.05

108.9

18

0.053

2.74

2.79

2.93

105.0

OPTION  B - The Hyper Sensitive Method

(For a quick guide, refer to Table 6.)

1 Dilute the wash buffer concentrate appropriately.
2 Equilibrate reagents and samples to room temperature before use. (Cold reagents will slow down the reaction and warming up rate will be different from tube to tube.)
3 Label test tubes in duplicate for each standard (0 -100 µIU/ml), control serum and patient samples.
4 Homogenize all reagents and patient samples by gentle mixing. Avoid foaming.
5 Pipette 200 µl of standards, control and patient samples into the bottom of labelled tubes.
6 Pipette 200 µl of tracer into each tube. Total count tubes should be set aside for counting.
7 Incubate tubes for 45 minutes at room temperature (20–28 °C).
8 Vigorously shake and swirl the bottle containing magnetic immunosorbent until homogeneity is achieved. Add 500 µl MIS to each tube. Swirl the bottle of MIS after every 15-20 tubes.
9 Thoroughly vortex mix all tubes. and incubate them for 15 minutes at room temperature.
10 Attach the rack on to the magnetic separator base and ensure that every tube is in contact with the base plate. Let the MIS particles settle for 5 minutes. Do not remove the rack from the separator base after the separation of the solid and liquid phases. Pour off and discard the supernatant. Keeping the separator inverted. place the tubes on a pad of absorbent tissue and allow to drain for 2 minutes.
11 Return the separator to an upright position and add 1.0 ml of washing solution to each tube. For more comfort and precision. it is recommended to use either a repeating pipette (e.g. Eppendorf pipette) or a dispenser with bottle for the addition of washing solution.
12 Vortex mix each tube thoroughly and repeat Step 10. Intense vortexing is required.
13 Count each tube for at least 60 seconds in a gamma counter.
14 Calculate the TSH concentration of the samples as described in Calculation of results or use special software.

Table 6. Assay Protocol, Pipetting Guide for OPTION B
All volumes are in microliters (µl).

Tube

Total

Standard

Sample

Control

Standard

 

200

   

Sample

   

200

 

Control

     

200

Tracer

(200)

200

200

200

Vortex mix
Incubate for 45 minutes at room temperature

Magnetic immunosorbent

 

500

500

500

Vortex mix
Incubate for 15 minutes at room temperature

Place the tubes on the magnetic separator for 5 minutes.

Decant the fluid and blot on filter paper

Wash Buffer

 

1000

1000

1000

Vortex mix.

Place the tubes on the magnetic separator for 5 minutes.

Decant the fluid and blot on filter paper

Count radioactivity (60 sec/tube)

Calculate the results.

Characterization of the assay for OPTION B

Typical standard curve for the Turbo TSH I-125 IRMA kit (Option B)
Figure 2.
OPTION B Typical standard curve corresponding to Table 7.
(Do not use to calculate sample values!)

Table 7. Typical assay data for OPTION B

 

CPM
1

CPM
2

CPM
mean

B/T %

Total

408 066

405 954

407 010

-

S0 (NSB)

54

90

72

0.018

S0.06

478

522

500

0.123

S0.15

895

1 037

966

0.237

S0.6

3 864

3 642

3 753

0.922

S2.5

15 321

14 229

14 775

3.63

S15

82 328

84 720

83 524

20.52

S50

218 273

215 871

217 072

53.33

S100 (Bmax)

310 516

308 014

309 265

75.99

CI

1 906

2 088

1 997

0.30

CII

121 274

119 754

120 514

19.3

Sensitivity

The analytical sensitivity or minimum detectable limit is calculated by the interpolation of the mean counts of zero standard plus 2 standard deviation from the standard curve. Determination was carried out using 20 replicates of zero standard response.

The value of analytical sensitivity is 0.008 µIU/ml measured using fresh tracer.

The functional sensitivity is a measure of the hTSH concentration that is significantly different from zero as determined by the inter-assay precision profile (22% CV).

The value of functional sensitivity is: 0.05 µIU/ml.

Hook effect

There is no high dose hook effect up to an hTSH concentration 500 µIU/ml.

Precision

The within-assay precision was determined with 15 replicates within a single run. the between-assay precision was estimated in 15 independent runs carried out in duplicates. CV values are summarized below:

Table 8/1.

 

intra-assay

sample No.

mean (µIU/ml)

CV %

1

0.040

39.6

2

0.062

18.5

3

0.082

13.4

4

0.101

13.7

5

0.128

16.1

6

0.135

10.3

7

0.199

3.8

8

0.289

7.4

9

0.609

2.2

10

0.710

2.4

11

0.964

1.9

12

1.17

2.8

13

1.80

2.1

14

3.17

1.6

15

6.39

2.9

16

19.47

1.8

17

22.12

1.5

The between-assay (inter-assay) precision was determined using pooled human serum samples in independent assay runs. The number of measurements on a sample was a function of sample volume available. Three different operators took part in the investigation process and four different tracer batches were used at different ages of the reagents. Four different lots of MIS were used to determine the inter-assay precision profile. Results are presented below.

Table 8/2.

   

inter-assay

sample No.

number of assay runs

mean (µIU/ml)

CV %

1

19

0.036

28.5

2

19

0.061

16.7

3

19

0.080

9.1

4

14

0.094

7.1

5

20

0.118

7.1

6

20

0.136

5.7

7

21

0.196

6.9

8

21

0.284

4.5

9

21

0.607

2.6

10

20

0.735

3.5

11

20

0.988

3.6

12

21

1.20

3.4

13

21

1.85

3.5

14

21

3.14

2.5

15

21

6.34

2.7

16

21

19.87

2.7

17

21

22.89

3.2

Linearity – dilution test

Individual human serum samples were diluted with the zero standard of the kit. The diluted samples were measured according to kit protocol.

Table 9.

sample
No.

dilution factor

expected µIU/ml

observed µIU/ml

recovery
%

1

1

 

12.31

 

1

2.02

6.11

5.89

96.4

1

4.08

3.02

2.91

96.5

1

8.23

1.50

1.47

98.0

2

1

 

25.17

 

2

2.02

12.48

12.24

98.1

2

4.05

6.22

6.07

97.7

2

8.14

3.09

3.01

97.4

3

1

 

32.81

 

3

1.99

16.47

15.68

95.2

3

3.97

8.26

7.83

94.9

3

7.92

4.14

3.97

95.8

4

1

 

12.92

 

4

1.99

6.48

6.73

103.8

4

3.97

3.25

3.37

103.7

4

7.96

1.62

1.69

104.2

5

1

 

30.55

 

5

2.03

15.06

14.48

96.1

5

4.12

7.42

6.54

88.1

5

8.33

3.67

3.29

89.7

6

1

 

1.43

 

6

2.03

0.705

0.687

97.5

6

4.10

0.349

0.341

97.8

6

8.33

0.172

0.158

92.0

7

1

 

22.99

 

7

2.00

11.46

11.74

102.4

7

4.04

5.69

5.87

103.1

7

8.12

2.83

2.91

102.8

8

1

 

0.867

 

8

2.02

0.429

0.411

95.9

8

4.09

0.212

0.195

92.0

8

8.25

0.105

0.092

87.5

9

1

 

1.88

 

9

2.00

0.938

0.930

99.1

9

4.00

0.470

0.472

100.5

9

8.00

0.235

0.233

99.3

10

1

 

14.13

 

10

2.02

7.01

7.08

101.0

10

4.05

3.49

3.57

102.3

10

8.18

1.73

1.69

98.0

Recovery – addition test

Individual human serum samples were spiked with known amount of an elevated stock sample. Recovery % is to be interpreted as = (observed-base)/added*100. The results are summarized below.

Table 10.

sample

basic µIU/ml

added µIU/ml

expected µIU/ml

observed µIU/ml

recovery
%

1

0.916

14.80

15.72

13.75

86.7

2

0.613

14.59

15.21

13.50

88.3

3

1.02

14.69

15.71

13.87

87.5

4

0.809

14.77

15.58

14.18

90.5

5

1.86

14.44

16.30

15.48

94.4

6

0.215

2.90

3.11

3.40

110.0

7

0.006

2.77

2.78

2.95

106.3

8

0.007

2.82

2.83

3.04

107.6

9

0.025

2.85

2.88

3.09

107.4

10

0.032

2.77

2.80

3.34

119.4

11

0.126

3.78

3.90

4.23

108.5

12

0.076

2.86

2.93

3.09

105.5

13

0.024

3.24

3.26

3.35

102.7

14

0.062

2.82

2.89

3.39

117.9

15

0.011

2.87

2.88

3.05

106.0

16

0.027

3.11

3.14

3.28

104.6

17

0.001

3.56

3.56

3.80

106.9

18

0.042

2.78

2.82

2.99

106.1

19

0.007

3.51

3.52

3.64

103.5

20

0.004

2.78

2.78

2.94

105.8

21

0.003

3.27

3.27

3.50

106.9

22

0.011

2.76

2.77

3.02

108.9

23

0.916 14.80 15.72 13.75 86.7

Option independent data

Specificity

No cross reactivity with hFSH and hTSH can be detected in normal physiological concentrations. 2 000 mIU/ml hCG gives an apparent 3.5 µIU/ml increase in hTSH concentration.

Expected Values

Expected euthyroid range is 0.25 µIU/ml - 3.55 µIU/ml.

It is recommended that each laboratory determine a reference range for euthyroids for its own patient population. since this may vary in different laboratories or regions.

Calculation of results

The calculation is illustrated using representative data. The assay data collected should be similar to those shown in Table 2 / 7.

Calculate the average count per minute (cpm) for each pair of assay tubes. Calculate the normalized percent binding for each standard, control and sample respectively by using the following equation:

  Standard [Control, Sample] (cpm)  
B / T (%) =  ————————————   x 100
  T (cpm)  

Using logarithmic graph paper plot B/T (%) for each standard versus the corresponding concentration of hTSH.

Determine the hTSH concentration of the controls & unknown samples by interpolation from the standard curve. Automated data processing systems are also applicable.

Additional information

Components from various lots or from kits of different manufacturers should not be mixed or interchanged.

Precaution

Radioactivity

This product contains radioactive material. It is the responsibility of the user to ensure that local regulations or code of practice related to the handling of radioactive materials are satisfied.

Biohazard

Human blood products used in the kit have been obtained from healthy human donors. They were tested individually by using approved methods (EIA. enzyme immunoassay). and were found to be negative. for the presence of both Human Immunodeficiency Virus antibody (Anti-HIV-1) and Hepatitis B surface Antigen (HBsAg).

Care should always be taken when handling human specimens to be tested with diagnostic kits. Even if the subject has been tested. no method can offer complete assurance that Hepatitis B Virus. Human Immunodeficiency Virus (HIV-1) or other infectious agents are absent. Human blood samples should therefore be handled as potentially infectious materials.

Chemical hazard

Components contain sodium azide as an antimicrobial agent. Dispose of waste by flushing with copious amount of water to avoid build-up of explosive metallic azides in copper and lead plumbing. The total azide present in each pack is 74 mg.

 

Use by In vitro diagnostic medical device Control
Batch code Manufacturer Standard
Caution, consult accompanying documents Radioactive material Magnetic immunosorbent
Biological risk Temperature limitation
Store between 2-8 °C
Tracer
Consult operating instructions Catalogue number Wash buffer


  Frequently asked questions about TurboTSH
Other thyroid function assays    
Calcitonin IRMA test RK-83M    
Anti-hTG RIA test RK-8CT T4 RIA test RK-11M1
TG IRMA test RK-51CT T4 RIA test RK-11M5
Anti-TPO RIA test RK-36CT T4 RIA test RK-11CT1
Turbo TSH IRMA test RK-1M2 T4 RIA test RK-11CT5
Turbo TSH IRMA test RK-1M5 Free T3 RIA test RK-33CT
Turbo TSH IRMA test RK-1CT1 T3 RIA test RK-6M1
Turbo TSH IRMA test RK-1CT5 T3 RIA test RK-6M5
Free T4 RIA test RK-34M1 T3 RIA test RK-6CT1
Free T4 RIA test RK-34CT1 T3 RIA test RK-6CT5
Other immunoassay kits      
    PRINTABLE VERSION
    PDF-FORMAT

Turbo TSH (thyroid stimulating hormone) IRMA test